Short Sleep Duration Linked to Emotional and Behavioral Symptoms in Children
In boys but not girls, reduced sleep duration at age 8 and 10 years predicted the development of behavioral disorder symptoms 2 years later.
Attention-Deficit/Hyperactivity Disorder
Video Game Based Digital Therapy Looks Promising in Pediatric ADHD Trial
Akili Interactive announced topline data from an open-label study (STARS-ADHD Adjunctive) of AKL-T01 for the treatment of attention deficit hyperactivity disorder in children with or without use of stimulants.
One in Four Children With Autism Not Formally Diagnosed
Autism spectrum disorder (ASD) remains underdiagnosed in black and Hispanic children.
Behavioral Interventions Beneficial for ADHD
Researchers sought to identify the major leading nonpharmaceutical intervention for ADHD cognitive symptomology, as well as which cognitive symptoms are most amenable to change.
Fetal Exposure to Acetaminophen May Increase Risk for ADHD and Autism
Cord biomarkers of fetal exposure to acetaminophen are associated with an increased risk for childhood ADHD and autism spectrum disorder.
Quality Evidence for Use of Cannabinoids to Treat Mental Disorders Lacking
There is little evidence to suggest that cannabinoids improve mental disorders.
FDA and FTC Issue Joint Warning Letter to Company Selling Unproven CBD Products
Company claimed their CBD products can be used to treat a variety of conditions and diseases including teething pain and earaches in infants, skin problems, autism, ADHD, Parkinson disease, and Alzheimer disease, among others.
Prevalence of Pediatric Developmental Disability Has Increased Over Last Decade
Between 2009 and 2017, the prevalence of developmental disability increased among US children aged 3 to 17 years.
Recommendations Updated for Management of Pediatric ADHD
In a clinical practice guideline, updated recommendations are presented for the evaluation and management of attention-deficit/hyperactivity disorder (ADHD) in children.
Gestational Exposure to Paracetamol Increases Risk for Childhood Attention Problems and Hyperactivity
Maternal paracetamol use during 18 to 32 weeks of gestation is associated with a higher risk for attention problems and hyperactivity in children 42 to 47 months of age.
Next post in Neurobehavioral Disorders
